Advent, Bain gain edge in bid for Pfizer's Brazil venture -sources


Oct 21 Bain Capital LP, Advent International Corp and Torrent Capital Investment Corp are on a shortlist of suitors for a Brazilian generic drug making joint-venture in which Pfizer Inc has a 40 percent stake, two people with direct knowledge of the situation said on Friday. According to the people, the three buyout firms presented more attractive terms than other drugmakers, including Israel's Teva Pharmaceutical Industries Ltd and Sun Pharmaceutical Industries Ltd, did for Teuto A sale could bring between 1 billion reais and 1.5 billion reais , they said.



from Biotech News